Literature DB >> 17218329

Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis.

R N Jois, N Kerrigan, D G I Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218329     DOI: 10.1093/rheumatology/kel417

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

Review 1.  Chronic Periaortitis: an Update.

Authors:  Alessandra Palmisano; Federica Maritati; Augusto Vaglio
Journal:  Curr Rheumatol Rep       Date:  2018-11-05       Impact factor: 4.592

Review 2.  Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease.

Authors:  Giovanni Maria Rossi; Rossana Rocco; Eugenia Accorsi Buttini; Chiara Marvisi; Augusto Vaglio
Journal:  Intern Emerg Med       Date:  2017-01-09       Impact factor: 3.397

Review 3.  Idiopathic Retroperitoneal Fibrosis.

Authors:  Augusto Vaglio; Federica Maritati
Journal:  J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 10.121

4.  Idiopathic Retroperitoneal Fibrosis: An East African Diagnostic Challenge.

Authors:  Sayed K Ali; Katie Du; Kelvin Orare
Journal:  Cureus       Date:  2021-06-16

5.  Medical management of retroperitoneal fibrosis.

Authors:  Paul J Scheel; Stephen M Sozio; Nancy Feeley
Journal:  Trans Am Clin Climatol Assoc       Date:  2012

Review 6.  Antifibrosis: to reverse the irreversible.

Authors:  Ziv Paz; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

7.  Mycophenolate mofetil in the treatment of retroperitoneal fibrosis.

Authors:  Fareeha Khalil; M A Mir; Rocco C Venuto
Journal:  Clin Rheumatol       Date:  2008-01-08       Impact factor: 2.980

8.  Retroperitoneal fibrosis: retrospective descriptive study on clinical features and management.

Authors:  Ann-Sophie Laroche; Robert Z Bell; Sarah Bezzaoucha; Eva Földes; Caroline Lamarche; Michel Vallée
Journal:  Res Rep Urol       Date:  2016-10-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.